Web News Insider
-
Model Finds DNA Mutations Alone Could Cap Median Human Lifespan at 146 to 194 Years
WASHINGTON, July 14 — The global race to slow human aging is no longer a fringe scientific pursuit; it is a strategic…
-
Innate vs. Adaptive Immunity: Two-Layered Defense System
MANILA, July 14 — For families across Asia, the idea of being protected from a disease long after recovery is something many…
-
Jean Twenge Ties the Teen Mental Health Slide After 2012 to Smartphones and Social Media
MANILA, July 14 — For communities across Asia watching their children grow up with smartphones and tablets in hand, the research of…
-
Heavy Screen Time Linked to Shorter Attention Spans in Children, Studies Find
LONDON, July 14 — The relationship between children’s screen time and cognitive development has come under renewed scrutiny, with research pointing to…
-
Next-Generation CAR T-Cell Therapies Aim at Solid Tumors and Off-the-Shelf Donor Cells
SAN FRANCISCO, July 14 — The next generation of cancer immunotherapy is racing toward a milestone that could change how thousands of…
-
Geneticist Nir Barzilai’s TAME Metformin Aging Trial Still Waits for Funding
NEW YORK, July 14 — The figure that matters: 200. That is the number of peer-reviewed papers Dr. Nir Barzilai has published…
-
New Alzheimer’s Drug Lecanemab Slows Cognitive Decline in Trial
WASHINGTON, July 14 — For the millions of American families watching a loved one slowly lose their memories, the arrival of lecanemab…
-
The Black Sea Grain Initiative: A Deal That Collapsed in 2023
ISTANBUL, July 14 — The Black Sea Grain Initiative, a diplomatic arrangement that once allowed over 32 million metric tons of grain…
-
James Allison’s CTLA-4 Discovery Pioneered Cancer Checkpoint Therapy
HOUSTON, July 14 — The technical reality of cancer immunotherapy is that the body’s own T cells often have the means to…
-
Vaccine Development Timeline: From 1796 to mRNA in 2020
ROME, July 14 — For families, the story of vaccines is not a dry list of dates and laboratories. It is the…
-
How the Dollar Reserve System Drives Global Trade and Finance
BEIJING, July 14 — The 1974 agreement between the United States and Saudi Arabia to price oil exclusively in dollars remains the…
-
The Hallmarks of Aging: What Drives Cellular Decline, Now 12 in Number
WASHINGTON, July 14 — A scientific framework first laid out in 2013 has become the dominant map for researchers trying to understand…
-
Immunotherapy harnesses immune system to fight cancer tumors
NEW YORK, July 14 — When James Allison and Tasuku Honjo shared the Nobel Prize in Physiology or Medicine in 2018, they…
-
Antiques Roadshow Expert Theo Burrell Dies at 39 After Four-Year Brain Cancer Fight
LONDON, July 14 — Theo Burrell’s four-year battle with brain cancer ended at age 39, and her death has prompted renewed calls…
-
How Joseph Meister Became the First Person Given Pasteur’s Rabies Vaccine
PARIS, July 14 — One hundred and thirty-nine years after a nine-year-old boy became the first human to survive a rabies infection…
-
HDT Bio Takes Glioblastoma Immunotherapy HDT-401 Toward a Phase 1 Trial at McGill
MONTREAL, July 13 — McGill University has announced a new partnership with HDT Bio, a biotechnology firm, to advance clinical trials for…
-
Dr. Colin Haile leads UH fight against fentanyl with vaccine
HOUSTON, July 13 — A vaccine candidate designed to neutralise fentanyl and its illicit chemical cousins has cleared an early scientific hurdle,…
-
Experimental vaccine shields mice from fentanyl and its chemical relatives
WASHINGTON — Inside a laboratory, a small group of mice is changing how researchers think about the opioid crisis. These animals, immunized…
-
Scripps Chemist Develops Vaccine To Train Immune System Against Fentanyl
LA JOLLA — Dr. Kim D. Janda is working on a vaccine that could change how the country fights the fentanyl crisis.…
-
Fine Particulate Matter Harms the Body and May Raise Dementia Risk
WASHINGTON — A growing body of evidence is drawing a clearer line between the air we breathe and the developing brains of…
-
Fentanyl Vaccine That Keeps the Drug Out of the Brain Is Set for Human Trials
ISLAMABAD, July 13 — A vaccine candidate designed to block fentanyl from reaching the brain has completed preclinical studies in animals, with…
-
Synthetic opioid deaths rose more than 23-fold from 2013 to 2023 before a 2024 drop
WASHINGTON, July 13 — The opioid crisis in the United States has reached unprecedented levels, with the Centers for Disease Control and…
-
Overdose deaths hit record high in 2021, fentanyl drives surge
WASHINGTON, July 13 — The opioid crisis in the United States has escalated dramatically over the past two decades, with synthetic opioids…
-
University of Houston Fentanyl Vaccine Targets Drug’s Chemical Backbone
HOUSTON, July 13 — A novel vaccine candidate developed at the University of Houston is targeting the chemical backbone of fentanyl and…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992